| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 08/11/2011 | WO2011097149A2 Taxane-and taxoid-protein compositions |
| 08/11/2011 | WO2011097081A2 Methods and compositions for oxygenation of skin to treat skin disorders |
| 08/11/2011 | WO2011096953A1 Oral antidepressant formulation with reduced excipient load |
| 08/11/2011 | WO2011096909A1 Pharmaceutical compositions comprising fluticasone, tiotropium and sodium cromoglycate |
| 08/11/2011 | WO2011096827A1 Treatment delivery device |
| 08/11/2011 | WO2011096566A1 Adhesive patch for treatment of tinea unguium |
| 08/11/2011 | WO2011096558A1 Easy-disintegrating polymeric micelle composition |
| 08/11/2011 | WO2011096513A1 Eye drops |
| 08/11/2011 | WO2011096230A1 Magnetic particles, process for producing same, and medicinal preparation including magnetic particles |
| 08/11/2011 | WO2011095973A1 Extended release formulations of rasagiline and uses thereof |
| 08/11/2011 | WO2011095970A1 Hair follicle targeting compositions |
| 08/11/2011 | WO2011095938A1 Liposomes containing prostaglandin e1 (pge1), formulations containing them and their use |
| 08/11/2011 | WO2011095801A2 Pharmaceutical composition |
| 08/11/2011 | WO2011095661A1 Magnetic nanoparticles for use in a pharmaceutical composition |
| 08/11/2011 | WO2011095588A1 Pharmaceutical composition comprising n-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-5-thiazolecarboxamid |
| 08/11/2011 | WO2011095579A1 4-[-2-[[5-methyl-1-(2-naphtalenyl)-1h-pyrazol-3-yl]oxy]ethyl]morpholine hydrochloride polymorphs and solvates |
| 08/11/2011 | WO2011095543A1 Immunoglobulin preparation |
| 08/11/2011 | WO2011095388A1 Tolterodine bead |
| 08/11/2011 | WO2011095353A1 Active antimicrobial compositions, coatings and methods for controlling pathogenic bacteria |
| 08/11/2011 | WO2011095314A2 Preparation of a powdery pharmaceutical composition by means of an extruder |
| 08/11/2011 | WO2011095021A1 Use of black soybean seedcoat extracts in manufacture of products for preventing and treating osteoarthritis |
| 08/11/2011 | WO2011094982A1 Solid formulation of clopidogrel bisulfate and preparation method thereof |
| 08/11/2011 | WO2011073995A3 Liquid vaginal spray of progesterone |
| 08/11/2011 | WO2011073245A3 Granules for pharmaceutical preparations, methods and apparatus for their production |
| 08/11/2011 | WO2011058475A3 Determination of the quality of the seal of sealed capsules using a microwave resonator and related equipment for in-line inspection |
| 08/11/2011 | WO2011055083A3 Multilayer pharmaceutical composition that can be dispersed in water and which contains a combination of antimalarial agents |
| 08/11/2011 | WO2011054516A3 Methods and compositions for producing tobacco products containing hydrogel capsules coated for low permeability and physical integrity |
| 08/11/2011 | WO2011053803A3 Multi-functional biodegradable particles for selectable targeting, imaging, and therapeutic delivery and use thereof for treating ocular disorders |
| 08/11/2011 | WO2011051924A4 Method of wound treatment using liquid gallium nitrate |
| 08/11/2011 | WO2011048494A3 Novel gastroretentive dosage forms of poorly soluble drugs |
| 08/11/2011 | WO2011045774A4 Extended release pharmaceutical compositions of paliperidone and processes of preparation thereof |
| 08/11/2011 | WO2011038014A3 Composition and method for treatment of diabetes |
| 08/11/2011 | WO2011031849A3 Anionic lipids and lipid nanostructures and methods of producing and using same |
| 08/11/2011 | WO2011015701A3 Lipid nanoparticles for gene therapy |
| 08/11/2011 | WO2011013003A3 Intranasal granisetron and nasal applicator |
| 08/11/2011 | WO2011012322A9 Synthesis and use of vildagliptin for the preparation of pharmaceutical dosage forms |
| 08/11/2011 | WO2010146408A3 Nanoparticulate olmesartan medoxomil compositions, process for the preparation thereof and pharmaceutical compositions containing them |
| 08/11/2011 | WO2010104563A3 Highly compactable and durable direct compression excipients and excipient systems |
| 08/11/2011 | WO2010100219A3 Pharmaceutical composition containing rasagiline mesylate |
| 08/11/2011 | WO2010093944A3 Delayed release, oral dosage compositions that contain amorphous cddo-me |
| 08/11/2011 | WO2010091822A8 N-hydroxylated amidine-, guanidine- and/or aminohydrazone-type prodrugs for application on the skin |
| 08/11/2011 | WO2006058249A3 Methods and compositions for deterring abuse of orally administered pharmaceutical products |
| 08/11/2011 | US20110197294 Compositions and methods for restoring mitochondrial electron transfer function |
| 08/11/2011 | US20110196502 Methods of Using Water-Soluble Inorganic Compounds for Implants |
| 08/11/2011 | US20110196474 Magnetically sensitive drug carriers for treatment or targeted delivery |
| 08/11/2011 | US20110196285 Hollow Mesoporous Silica Sphere Coated with Gold and Preparation Method Thereof and Use in Cancer Therapy |
| 08/11/2011 | US20110196043 Methods and compositions for administration of trpv1 agonists |
| 08/11/2011 | US20110196039 Controlled release arginine formulations |
| 08/11/2011 | US20110195456 Methods and compositions for the production of monoclonal antibodies |
| 08/11/2011 | US20110195156 Sustained release beads and suspensions including the same for sustained delivery of active ingredients |
| 08/11/2011 | US20110195127 Compositions and methods for silencing apolipoprotein b |
| 08/11/2011 | US20110195126 Peptide-coated nanoparticles with graded shell compositions |
| 08/11/2011 | US20110195125 Nanoparticles For Drug Delivery To The Central Nervous System |
| 08/11/2011 | US20110195124 Phase-transition polymeric microneedles |
| 08/11/2011 | US20110195123 Methods, compositions and systems for local delivery of drugs |
| 08/11/2011 | US20110195122 Extended Release Formulation |
| 08/11/2011 | US20110195121 chronotherapeutic pharmaceutical dosage form |
| 08/11/2011 | US20110195120 Sustained Release Pharmaceutical Composition Containing Metformin Hydrochloride |
| 08/11/2011 | US20110195119 Controlled release metformin formulations |
| 08/11/2011 | US20110195118 Process for Producing Oral Dosage Forms With Controlled Release |
| 08/11/2011 | US20110195117 Controlled release compositions of ropinirole |
| 08/11/2011 | US20110195116 Rate modulated delivery of drugs from a composite delivery system |
| 08/11/2011 | US20110195115 Hydrophilic amino acid-containing preparation having improved taste |
| 08/11/2011 | US20110195114 Transdermal delivery systems for active agents |
| 08/11/2011 | US20110195113 Virus-like particles comprising composite capsid amino acid sequences for enhanced cross reactivity |
| 08/11/2011 | US20110195112 Use of plant-derived recombinant growth factors in skin care |
| 08/11/2011 | US20110195111 Aqueous compositions and methods |
| 08/11/2011 | US20110195110 Urea compounds useful in the treatment of cancer |
| 08/11/2011 | US20110195109 Adhesive skin patch and packaged product |
| 08/11/2011 | US20110195108 Antiviral agent |
| 08/11/2011 | US20110195103 Cosmetic or dermopharmaceutical composition containing pseudoalteromonas ferment extract |
| 08/11/2011 | US20110195102 Peptides useful in the treatment and/or care of skin, mucous membranes, scalp and/or hair and their use in cosmetic or pharmaceutical compositions |
| 08/11/2011 | US20110195101 Polysaccharide Capsules and Methods of Preparation |
| 08/11/2011 | US20110195097 Composition and dosage form comprising a particle formulation and suspending vehicle |
| 08/11/2011 | US20110195096 Compositions and methods for treating inflammatory disorders |
| 08/11/2011 | US20110195095 Injectable nanoparticulate olanzapine formulations |
| 08/11/2011 | US20110195031 Methods for the use of progestogen as a glucocorticoid sensitizer |
| 08/11/2011 | US20110195030 Nanoparticle compositions comprising liquid oil cores |
| 08/11/2011 | US20110195019 Nucleic acids and corresponding proteins entitled 251p5g2 useful in treatment and detection of cancer |
| 08/11/2011 | US20110192493 Liquid Pharmaceutical Formulations of Palonosetron |
| 08/11/2011 | US20110192354 Methods and apparel for simultaneously attenuating electromagnetic fields and odors emanating from a person |
| 08/11/2011 | DE202011102391U1 Wachs-Servietten zur Wärmebehandlung und Vorichtung zur Herstellung im Tauchvervahren Wax napkins for heat treatment and Vorichtung for the production in Tauchvervahren |
| 08/11/2011 | DE102010026879A1 Transdermal system, useful for indicating and preventing multiple sclerosis, immunomodulator including quinolines or isoxazoles, metabolite forming groups, skin protective layer, a reservoir and a carrier impermeable to active substance |
| 08/11/2011 | CA2825424A1 Biomineral and metal binding liposomes, their synthesis, and methods of use thereof |
| 08/11/2011 | CA2789033A1 Low-permeability, laser-activated drug delivery device |
| 08/11/2011 | CA2789006A1 Extended release formulations of rasagiline and uses thereof |
| 08/11/2011 | CA2788980A1 Hair follicle targeting compositions |
| 08/11/2011 | CA2788863A1 Immunoglobulin preparation |
| 08/11/2011 | CA2788749A1 Pharmaceutical composition comprising n-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-5-thiazolecarboxamid |
| 08/11/2011 | CA2788740A1 Directly compressible magnesium hydroxide carbonate |
| 08/11/2011 | CA2788669A1 Bismuth-thiols as antiseptics for biomedical uses, including treatment of bacterial biofilms and other uses |
| 08/11/2011 | CA2788663A1 Taxane-and taxoid-protein compositions |
| 08/11/2011 | CA2788401A1 Composition |
| 08/11/2011 | CA2788347A1 Disruptive polymer micelle composition |
| 08/11/2011 | CA2788024A1 4-[-2-[[5-methyl-1-(2-naphtalenyl)-1h-pyrazol-3-yl]oxy]ethyl]morpholine hydrochloride polymorphs and solvates |
| 08/11/2011 | CA2787725A1 Liposomes containing prostaglandin e1 (pge1), formulations containing them and their use |
| 08/10/2011 | EP2353612A1 Injectable in-situ crosslinked hydrogel and the preparation method and use thereof |
| 08/10/2011 | EP2353606A2 Compositions and methods for the treatment of CNS injuries |
| 08/10/2011 | EP2353590A1 Aerosol and injectable formulations of nanoparticulate benzodiazepine |
| 08/10/2011 | EP2353588A1 A sustained preparation of factor IX |